SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer
May 24, 2023 at 06:30 pm IST
Share
SANUWAVE Health, Inc. announced that its Board of Directors has appointed Morgan Frank as Chief Executive Officer. Frank, a company development, corporate restarts, and capital markets veteran, has served 19 years as founder and principal of Manchester Management (Manchester Explorer Fund), the Company's largest outside shareholder and has served as Chairman of the SANUWAVE Board of Directors since August 2022. Kevin Richardson, the Company's former CEO, will remain on the Board of Directors of the Company and continue an active role in the Company, serving as its Chief Strategic Officer during this exciting period of growth and opportunity for the Company.
Before joining the Company, Frank, 51, has served 19 years as principal at Manchester Management LLC, the Company's largest outside shareholder. He brings with him 29 years of U.S. public equity and capital markets experience, with a focus in life sciences and technology as well as corporate restarts and intellectual property salvage and monetization. Mr. Frank has provided long term strategic planning, due diligence and business development strategy, and investor relations guidance to over 100 public companies and looks forward to working more deeply with SANUWAVE.
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The Company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and others. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing from within. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression (PACE) technology to converge at precise selected targets to produce an extremely short duration compression burst.